Weight-loss drugs and bariatric surgery both have an impact on cancer risk. A new study breaks down the link and how GLP-1 ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

Weekly jabs might not sound glamorous, but Mounjaro and Ozempic are making headlines for more than just managing blood sugar.

Weight-loss drugs like Ozempic and Wegovy could usher in a “golden age” of medicine due to their ability to delay diseases associated with ageing.

Researchers have found in a new study that semaglutide could provide cardiovascular benefits to high-risk patients even ...

The Daily Express also heralds a "golden age" of obesity-fighting drugs. Citing cardiologist Professor John Deanfield, it ...

Studies have shown that GLP-1s reduce inflammation in the brain and regulate anxiety as well as depression. When insurance ...

In addition to requests for double-digit premium increases, Blue Cross Blue Shield of Vermont is also cutting back on coverage of popular weight-loss drugs on some plans.

The top reasons weight loss supplements fail and why most solutions don't address both day and night fat-burning cycles; How PhenQ works as a powerful daytime fat burner to help r ...

A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

Fact checked by Nick Blackmer Tirzepatide and semaglutide, the ingredients in popular weight loss drugs, can both cause side ...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for the safe and ...